Intravenous thrombolysis with recombinant tissue plasminogen activator in a stroke patient treated with dabigatran

Cerebrovasc Dis. 2010;30(5):533-4. doi: 10.1159/000319886. Epub 2010 Sep 28.

Authors

Ann De Smedt¹, Sylvie De Raedt, Koenraad Nieboer, Jacques De Keyser, Raf Brouns

Affiliation

¹ Department of Neurology, Universitair Ziekenhuis Brussel, Laarbeeklaan 101, Brussels, Belgium.

PMID: 20881383
DOI: 10.1159/000319886

No abstract available

Publication types

Case Reports

MeSH terms

Administration, Oral
Anticoagulants / administration & dosage
Anticoagulants / therapeutic use*
Benzimidazoles / administration & dosage
Benzimidazoles / therapeutic use*
Cerebral Angiography
Dabigatran
Drug Therapy, Combination
Female
Humans
Injections, Intravenous
Middle Aged
Recombinant Proteins / administration & dosage
Recombinant Proteins / therapeutic use*
Stroke / diagnostic imaging
Stroke / drug therapy*
Thrombolytic Therapy
Tissue Plasminogen Activator / administration & dosage
Tissue Plasminogen Activator / therapeutic use*
Treatment Outcome
beta-Alanine / administration & dosage
beta-Alanine / analogs & derivatives*
beta-Alanine / therapeutic use

Substances

Anticoagulants
Benzimidazoles
Recombinant Proteins
beta-Alanine
Tissue Plasminogen Activator
Dabigatran